1. For IRB Members
  2. IEP IRB Member FAQ
  3. Brief Responsibilities of an HS-IRB Member
  4. Brief Responsibilities of an MR-IRB Member
  5. IRB Member FAQs
  6. Privacy & Confidentiality
  7. IRB Member Newsletter -- Volume 12 (Summer 2019)
  8. IRB Member Newsletter--Volume 11 (Spring 2018)
  9. Study Personnel Financial Conflicts of Interest and HS IRBs Review Guidance
  10. Children as research participants: Regulations
  11. IRB Member Newsletter--Scheduling Special Edition
  12. Initial Review Tips for IRB Members
  13. IRB Member Newsletter--Volume 9 (Summer 2015)
  14. Noncompliance, Protocol Exceptions and Deviations
  15. Pregnant Women, Fetuses and Neonates: Regulations
  16. Genetic Testing or Analysis
  17. IRB Member Newsletter--Volume 10 (Fall 2017)
  18. Scientist Screwed Up? Send 'em to Researcher Rehab (2017)
  19. What do revised U.S. rules mean for human research? (2017)
  20. The Nuremberg Code 70 Years Later (2017)
  21. How to Conduct PRS Review
  22. Making a Motion at IRB Meetings
  23. Reviewing Initial Applications In ARROW
  24. Drugs, Biologics, and Devices: Regulations
  25. Informed Consent Process, Elements, and Waivers
  26. New IRB Members Guide
  27. IRB Member Newsletter--Volume 8 (Winter 2013)
  28. IRB Member Newsletter--Volume 7 (Spring 2013)
  29. Primary Reviewer Guidance for Initial Reviews
  30. Guidance for UW Madison Health Sciences IRB & Minimal Risk IRB Primary Reviewers for Summarizing Initial Review Applications
  31. Overview of the Accreditation Process and UW-Madison's Human Research Protections Program
  32. IRB Member Newsletter--Volume 2 (Winter 2010)
  33. Finding Study-Related Documents in ARROW
  34. Cheat Sheet (w/ screenshots) for Initial Reviews in ARROW
  35. Brief Overview of Regulatory Basis of IRB Authority and Review Responsibilities
  36. IRB Member Newsletter--Volume 1 (Fall 2009)
  37. Continuing Review & Changes of Protocol
  38. Criteria for IRB Approval: 45 CFR 46.111 (DHHS), 21 CFR 56.111 (FDA), and 38 CFR 16.111 (VA)
  39. Belmont Report
  40. IRB Member Newsletter--Volume 5 (Spring/Summer 2012)
  41. How to Conduct a Modification Response Review in ARROW
  42. Unanticipated Problems and Serious Adverse Events
  43. Prisoners: Regulations
  44. Review Processes Other Than Full-Board
  45. IRB Member Newsletter--Volume 6 (Fall 2012)
  46. IRB Member Workspace Navigation Guide for IRB Members
  47. IRB Member Newsletter--Volume 3 (Summer 2011)
  48. How to Conduct a Deferral Response Review in ARROW
  49. IRB Member Newsletter--Volume 4 (Winter 2011/2012)
  50. Meeting Workspace Navigation Guide for IRB Members
  51. Article: Lessons from researcher rehab
  52. Article: A Broken Contract
  53. Article: Pediatric Magnetic Resonance Research and the Minimal-Risk Standard
  54. Article: Balancing Risks and Benefits in Clinical Trials
  55. Article: For Henrietta Lacks' Famous Cells, New and Unique Protection
  56. Article: As Data Overflows Online, Researchers Grapple With Ethics
  57. Article: Blood Samples Raise Questions of Privacy
  58. Article: The Importance of Purpose: Moving Beyond Consent in the Societal Use of Personal Health Information
  59. Article: Clinical Trials, Wrapped in Red Tape
  60. Article: Updating Research Oversight for the 21st Century
  61. Article: Disclosure of Financial Relationships to Participants in Clinical Research
  62. Article: Apple's New ResearchKit: 'Ethics Quagmire' or Medical Research Aid?
  63. Article: A Comprehensive Analysis of MRI Research Risks: In Support of Full Disclosure
  64. Article: Rx Risks Not Dislosed to Trial Participants
  65. Article: How Variability in the Institutional Review Board Review Process Affects Minimal-Risk Multisite Health Services Research